{"id":"seromycin","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute nephropathy","Alcoholism","CNS Toxicity","Cobalamin deficiency","Depressive disorder","Epilepsy","Folic acid deficiency","Kidney disease","Megaloblastic anemia","Psychotic disorder","Severe anxiety (panic)","Sideroblastic anemia"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02635893","NCT00864123","NCT05591677","NCT01733030","NCT01102803","NCT00674570","NCT07227103","NCT01490697","NCT00356278","NCT02735694","NCT00222235","NCT03062150","NCT00301080","NCT00926900","NCT00632632","NCT01512316","NCT01687140","NCT02376257","NCT01923896","NCT05081986","NCT01037101","NCT00000372","NCT03432689","NCT01550796","NCT07460947","NCT00352586","NCT00128401","NCT05994703","NCT05177601","NCT00131339","NCT04357951","NCT00000371","NCT00125528","NCT01526538","NCT01361633","NCT00963924","NCT00759473","NCT04035603","NCT00755820","NCT00126282","NCT05779267","NCT01068847","NCT03395392","NCT01343862","NCT00633256","NCT01680107","NCT02304432","NCT06121284","NCT00591825","NCT01135953"],"aliases":["D-Cycloserine","D-cycloserine"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"seromycin","companyId":"massachusetts-general-hospital","ecosystem":[],"mechanism":{"target":"Cytochrome P450 3A4, Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2A","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Massachusetts General Hospital","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"seromycin","indications":{"approved":[{"name":"Acute tuberculosis","diseaseId":"acute-tuberculosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial urinary infection","diseaseId":"bacterial-urinary-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Escherichia coli urinary tract infection","diseaseId":"escherichia-coli-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary tuberculosis","diseaseId":"pulmonary-tuberculosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02635893","phase":"Phase 4","title":"Lower Limb Function After Spinal Cord Injury","status":"COMPLETED","sponsor":"Shirley Ryan AbilityLab","isPivotal":false,"enrollment":257,"indication":"Spinal Cord Injury","completionDate":"2021-04-11"},{"nctId":"NCT00864123","phase":"Phase 2","title":"D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder","status":"COMPLETED","sponsor":"University of South Florida","isPivotal":false,"enrollment":30,"indication":"Obsessive-compulsive Disorder","completionDate":"2009-11"},{"nctId":"NCT05591677","phase":"Phase 2","title":"D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression: A Multi-Site, Randomised, Placebo-Controlled Trial (COGENT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Alfred","isPivotal":false,"enrollment":180,"indication":"Major Depressive Disorder","completionDate":"2026-05-29"},{"nctId":"NCT01733030","phase":"N/A","title":"The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear in Healthy Controls.","status":"COMPLETED","sponsor":"University of Minnesota","isPivotal":false,"enrollment":56,"indication":"Post Traumatic Stress Syndrome","completionDate":"2015-10-01"},{"nctId":"NCT01102803","phase":"Phase 3","title":"Evaluation of the Effects of Post-Session Administration of D-cycloserine On Exposure Therapy Outcomes","status":"COMPLETED","sponsor":"Southern Methodist University","isPivotal":true,"enrollment":40,"indication":"Phobic Disorders","completionDate":"2011-07"},{"nctId":"NCT00674570","phase":"Phase 4","title":"Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder","status":"COMPLETED","sponsor":"VA Office of Research and Development","isPivotal":false,"enrollment":111,"indication":"Stress Disorders, Posttraumatic","completionDate":"2015-06-22"},{"nctId":"NCT07227103","phase":"Phase 2","title":"A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression","status":"NOT_YET_RECRUITING","sponsor":"NeuroRx, Inc.","isPivotal":true,"enrollment":120,"indication":"Treatment Resistant Depression","completionDate":"2027-03-31"},{"nctId":"NCT01490697","phase":"Phase 4","title":"Developing Memory Reconsolidation Blockers as Novel PTSD Treatments","status":"COMPLETED","sponsor":"Roger K. Pitman, MD","isPivotal":false,"enrollment":34,"indication":"Post-traumatic Stress Disorder","completionDate":"2015-09"},{"nctId":"NCT00356278","phase":"Phase 2","title":"A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD","status":"COMPLETED","sponsor":"Emory University","isPivotal":true,"enrollment":156,"indication":"Stress Disorder, Post Traumatic","completionDate":"2014-06"},{"nctId":"NCT02735694","phase":"Phase 1","title":"Cycloserine in the Treatment of Sleep Apnea","status":"TERMINATED","sponsor":"University of Manitoba","isPivotal":false,"enrollment":18,"indication":"Sleep Apnea Syndromes","completionDate":"2016-11"},{"nctId":"NCT00222235","phase":"Phase 2","title":"Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","isPivotal":true,"enrollment":240,"indication":"Schizophrenia, Schizoaffective Disorder","completionDate":"2004-06"},{"nctId":"NCT03062150","phase":"NA","title":"Effects of Mineralocorticoid Receptor Stimulation on Cognitive Bias and Social Cognition in Patients With Major Depression and Healthy Controls: What's the Role of NMDA Receptors?","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","isPivotal":false,"enrollment":232,"indication":"Major Depression","completionDate":"2019-02-11"},{"nctId":"NCT00301080","phase":"Phase 3","title":"A Phase III Study of D-Cycloserine in the Management of Paclitaxel-Induced Peripheral Neuropathic Pain in Breast Cancer Patients","status":"TERMINATED","sponsor":"Northwestern University","isPivotal":true,"enrollment":7,"indication":"Neurotoxicity, Pain","completionDate":"2008-05"},{"nctId":"NCT00926900","phase":"Phase 2","title":"The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes","status":"UNKNOWN","sponsor":"Central Institute of Mental Health, Mannheim","isPivotal":true,"enrollment":80,"indication":"Alcohol Drinking","completionDate":""},{"nctId":"NCT00632632","phase":"NA","title":"Combined Exposure Therapy and D-Cycloserine vs. Placebo for Posttraumatic Stress Disorder","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","isPivotal":false,"enrollment":25,"indication":"Posttraumatic Stress Disorder","completionDate":"2012-12"},{"nctId":"NCT01512316","phase":"NA","title":"The Effect of D-cycloserine on Fear Learning and Extinction","status":"WITHDRAWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","isPivotal":false,"enrollment":0,"indication":"Healthy Individuals","completionDate":""},{"nctId":"NCT01687140","phase":"Phase 2","title":"The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder","status":"UNKNOWN","sponsor":"University of California, Los Angeles","isPivotal":false,"enrollment":26,"indication":"Obsessive-Compulsive Disorder","completionDate":"2014-07"},{"nctId":"NCT02376257","phase":"Phase 2","title":"Improving Therapeutic Learning in Depression: Proof of Concept","status":"COMPLETED","sponsor":"Boston University Charles River Campus","isPivotal":false,"enrollment":36,"indication":"Major Depressive Disorder","completionDate":"2017-05"},{"nctId":"NCT01923896","phase":"Phase 1","title":"Use of D-cycloserine to Facilitate Extinction of Food Aversion in Pediatric Populations","status":"COMPLETED","sponsor":"Emory University","isPivotal":false,"enrollment":16,"indication":"Feeding Disorders, Specific Phobia","completionDate":"2013-11"},{"nctId":"NCT05081986","phase":"Phase 2","title":"Motor Plasticity Enhancement of Spaced iTBS Trains: a Randomized, Placebo-controlled, Crossover Trial of D-cycloserine.","status":"COMPLETED","sponsor":"University of Calgary","isPivotal":false,"enrollment":20,"indication":"Motor Activity","completionDate":"2022-02-23"},{"nctId":"NCT01037101","phase":"NA","title":"D-Cycloserine as Enhancer of One-Session Treatment for Phobia of Heights in Adults","status":"UNKNOWN","sponsor":"CAMC Health System","isPivotal":false,"enrollment":80,"indication":"Height Phobia","completionDate":"2014-12"},{"nctId":"NCT00000372","phase":"Phase 3","title":"A Placebo Controlled Trial of Glycine Added to Clozapine in Schizophrenia","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","isPivotal":true,"enrollment":0,"indication":"Schizophrenia","completionDate":"2005-11"},{"nctId":"NCT03432689","phase":"Phase 1","title":"A Randomized, Placebo-controlled, Crossover Trial of Cycloserine Repetitive Transcranial Magnetic Stimulation Plasticity Enhancement in the Healthy Motor System.","status":"COMPLETED","sponsor":"University of Calgary","isPivotal":false,"enrollment":12,"indication":"Motor Activity","completionDate":"2018-11-07"},{"nctId":"NCT01550796","phase":"Phase 2","title":"Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine","status":"COMPLETED","sponsor":"Washington University School of Medicine","isPivotal":false,"enrollment":37,"indication":"Tinnitus","completionDate":"2012-06"},{"nctId":"NCT07460947","phase":"Phase 1","title":"A Pilot Trial of One Day Accelerated Intermittent Theta-burst Stimulation Plus D-cycloserine in Suicidal Patients With Borderline Personality Disorder (ONE-D BPD)","status":"NOT_YET_RECRUITING","sponsor":"Mclean Hospital","isPivotal":false,"enrollment":20,"indication":"Borderline Personality Disorder (BPD)","completionDate":"2027-12"},{"nctId":"NCT00352586","phase":"N/A","title":"Psychopharmacology Investigations of Fear Conditioning in Humans","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","isPivotal":false,"enrollment":160,"indication":"Fear","completionDate":"2008-02-01"},{"nctId":"NCT00128401","phase":"Phase 2","title":"Effect of D-Cycloserine on Treatment of Social Phobia","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","isPivotal":false,"enrollment":48,"indication":"Phobic Disorders, Anxiety","completionDate":"2012-08"},{"nctId":"NCT05994703","phase":"Phase 2","title":"Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine","status":"COMPLETED","sponsor":"Rose Research Center, LLC","isPivotal":false,"enrollment":25,"indication":"Smoking Cessation, Harm Reduction","completionDate":"2026-01-12"},{"nctId":"NCT05177601","phase":"Phase 2","title":"A Randomized Sham and Placebo-controlled Trial of Adjunctive D-cycloserine in Repetitive Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder","status":"UNKNOWN","sponsor":"University of Calgary","isPivotal":false,"enrollment":81,"indication":"Obsessive-Compulsive Disorder","completionDate":"2025-10"},{"nctId":"NCT00131339","phase":"NA","title":"Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Panic Disorder","status":"COMPLETED","sponsor":"Hartford Hospital","isPivotal":false,"enrollment":40,"indication":"Panic Disorder","completionDate":"2007-03"},{"nctId":"NCT04357951","phase":"EARLY/Phase 1","title":"D-cycloserine Augmented Treatment: Enhancing Extinction Learning in Youth With Tic Disorders","status":"WITHDRAWN","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":0,"indication":"Tourette Syndrome","completionDate":"2024-09"},{"nctId":"NCT00000371","phase":"Phase 3","title":"A Six Month, Placebo-Controlled Trial of D-Cycloserine Co-Administered With Conventional Antipsychotics in Schizophrenia Patients","status":"COMPLETED","sponsor":"Massachusetts General Hospital","isPivotal":true,"enrollment":60,"indication":"Schizophrenia","completionDate":"2002-04"},{"nctId":"NCT00125528","phase":"Phase 2","title":"D-Cycloserine in the Management of Chronic Low Back Pain: A Double-Blind, Randomized, Placebo-Controlled Pilot Study","status":"COMPLETED","sponsor":"Thomas J. Schnitzer","isPivotal":false,"enrollment":41,"indication":"Low Back Pain, Pain","completionDate":"2014-11"},{"nctId":"NCT01526538","phase":"Phase 2","title":"Improving Learning-based Treatment of Cocaine Dependence With Medication","status":"COMPLETED","sponsor":"Johns Hopkins University","isPivotal":false,"enrollment":52,"indication":"COCAINE-RELATED DISORDERS","completionDate":"2013-03"},{"nctId":"NCT01361633","phase":"Phase 2","title":"The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly","status":"COMPLETED","sponsor":"Hartford Hospital","isPivotal":false,"enrollment":51,"indication":"Treatment, Placebo","completionDate":"2009-02"},{"nctId":"NCT00963924","phase":"NA","title":"A Placebo-controlled Trial of D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","isPivotal":false,"enrollment":54,"indication":"Schizophrenia","completionDate":"2011-06"},{"nctId":"NCT00759473","phase":"Phase 2","title":"D-Cycloserine Facilitation of Cocaine - Cue Extinction","status":"COMPLETED","sponsor":"Medical University of South Carolina","isPivotal":false,"enrollment":79,"indication":"Cocaine Use Disorders","completionDate":"2011-10"},{"nctId":"NCT04035603","phase":"Phase 2","title":"Multimodal CET for Smoking Cessation Augmented With D-cycloserine","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","isPivotal":false,"enrollment":0,"indication":"Smoking Cessation","completionDate":"2021-01-31"},{"nctId":"NCT00755820","phase":"N/A","title":"Food Exposure Therapy in Anorexia Nervosa","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","isPivotal":false,"enrollment":32,"indication":"Anorexia Nervosa","completionDate":"2012-01"},{"nctId":"NCT00126282","phase":"NA","title":"A Randomized, Double-blind, Placebo-controlled Medication Trial With D-Cycloserine for Individuals With Obsessive-compulsive Disorder Currently Receiving Behavior Therapy","status":"COMPLETED","sponsor":"Massachusetts General Hospital","isPivotal":false,"enrollment":50,"indication":"Obsessive-Compulsive Disorder","completionDate":"2007-12"},{"nctId":"NCT05779267","phase":"N/A","title":"NRX-101 for Treatment-Resistant Bipolar Depression in Patients At Risk for Self-Harm","status":"AVAILABLE","sponsor":"NeuroRx, Inc.","isPivotal":false,"enrollment":0,"indication":"Bipolar Depression, Bipolar Affective Disorder","completionDate":""},{"nctId":"NCT01068847","phase":"Phase 1","title":"Drug Discrimination in Methadone-Maintained Humans Study 3","status":"COMPLETED","sponsor":"University of Arkansas","isPivotal":false,"enrollment":9,"indication":"Drug Dependence","completionDate":"2012-11"},{"nctId":"NCT03395392","phase":"Phase 2","title":"A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior","status":"COMPLETED","sponsor":"NeuroRx, Inc.","isPivotal":true,"enrollment":74,"indication":"Bipolar Depression, Suicidal Ideation and Behavior","completionDate":"2024-03-30"},{"nctId":"NCT01343862","phase":"Phase 2","title":"The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate TBI Patients","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","isPivotal":false,"enrollment":100,"indication":"Traumatic Brain Injury","completionDate":"2014-05"},{"nctId":"NCT00633256","phase":"NA","title":"The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers.","status":"COMPLETED","sponsor":"Yale University","isPivotal":false,"enrollment":20,"indication":"Smoking","completionDate":"2008-02"},{"nctId":"NCT01680107","phase":"Phase 3","title":"The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial","status":"TERMINATED","sponsor":"University of Oxford","isPivotal":true,"enrollment":33,"indication":"Panic Disorder","completionDate":"2018-04-30"},{"nctId":"NCT02304432","phase":"EARLY/Phase 1","title":"Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine","status":"COMPLETED","sponsor":"Mclean Hospital","isPivotal":false,"enrollment":2,"indication":"Schizophrenia, Bipolar Disorder","completionDate":"2017-07-31"},{"nctId":"NCT06121284","phase":"Phase 2","title":"A Randomized Placebo-controlled Trial of Adjunctive D-Cycloserine and Accelerated Intermittent Theta Burst Stimulation for Emerging Adults With Suicidal Ideation","status":"RECRUITING","sponsor":"University of Calgary","isPivotal":false,"enrollment":54,"indication":"Suicidal Ideation, Suicide, Attempted","completionDate":"2026-09"},{"nctId":"NCT00591825","phase":"Phase 2","title":"An fMRI Study Investigating the Effects of Acute D-cycloserine Administration on Brain Activations and Cognitive Functioning in Spider Phobia.","status":"COMPLETED","sponsor":"University of Kansas Medical Center","isPivotal":false,"enrollment":54,"indication":"Phobias","completionDate":"2012-12"},{"nctId":"NCT01135953","phase":"NA","title":"Investigating Methods to Enhance the Excitatory Effects of Transcranial Direct Stimulation (tDCS)","status":"COMPLETED","sponsor":"The University of New South Wales","isPivotal":false,"enrollment":24,"indication":"Healthy Volunteers, Brain Excitation","completionDate":"2010-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}